Then, we verified that the upregulation of WNT5A promoted ESCC cell metastasis in vivo and in vitro, suggesting that WNT5A might be a promising therapeutic target for the prevention of ESCC. This evidence concerns the gene WNT5A and esophageal squamous cell carcinoma.